Assistance Publique - Hôpitaux de Paris: COVID-19 trials

The registry lists 112 COVID-19 studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 2 12Phase 3 16No phase 85(a study in two phases counts in both)

Studies

Page 1 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France RegionNot yet recruitingNCT07882186
• Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)Not yet recruitingNCT07089719Phase 2
• Understanding the Impact of Death Conditions Linked to the COVID-19 Crisis on the Grieving Process in Bereaved FamiliesNot yet recruitingNCT05566366Not applicable
• Impact of Post-ARDS Covid-19 Sedation on Persistent NeuroinflammationRecruitingNCT05233605
• Impact of COVID-19 SARS-CoV-2 Variability in ICU Hospitalized Patients With Severe DiseaseRecruitingNCT05162508
• Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)RecruitingNCT04558450Not applicable
• Impact of COVID19 Outbreak in Cardiac Acute CareRecruitingNCT04344912
• Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19.CompletedNCT06683937
• Severe Group A Streptococcus Infections in Paris, France, 2018-2023CompletedNCT06297122
• Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.CompletedNCT05951920Not applicable
• Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA VaccineActive, not recruitingNCT05749926Phase 3
• A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)CompletedNCT05439044
• Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in AdultsActive, not recruitingNCT05405283Phase 3
• Covid-19 Vaccine Response in Heart Transplant RecipientsCompletedNCT05268679
• Foreign Body Ingestion During COVID-19 LockdownStatus unknownNCT05261074
• Prognosis of Geriatric Patients 1 Year After Hospitalization for COVID-19Status unknownNCT05261061
• Impact of the COVID-19 Pandemic on Mental Health Service Utilization in Children and AdolescentsCompletedNCT05260866
• Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19WithdrawnNCT05128656Not applicable
• Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary VaccinationStatus unknownNCT05124171Phase 3
• LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2CompletedNCT05113836
• Evaluation of the Detection Performance of the N Antigenemia of SARS-CoV-2 in the General Population for the Diagnosis and Screening of COVID-19Status unknownNCT05092607Not applicable
• Prognostic Value of IgM in Covid-19 InfectionStatus unknownNCT05092594
• Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple SclerosisCompletedNCT05033782
• Identification of Factors Associated With the Occurrence of Severe Forms of COVID-19 Infection in Patients With Inflammatory Rheumatism or Autoimmune DiseasesStatus unknownNCT05026892
• Project FLUx COntact-CoVID-19 Faculty of Medicine Paris-SaclayCompletedNCT04991246Not applicable
• Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)WithdrawnNCT04953312Not applicable
• Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19Status unknownNCT04930757
• Containment Impact on Primary Care & Adverse Events Unrelated to COVID-19 in Older Patients and/or With Chronic DiseasesStatus unknownNCT04907994
• Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA VaccineStatus unknownNCT04900467Not applicable
• The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT)CompletedNCT04881227Not applicable
• Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering EventCompletedNCT04872075Not applicable
• Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or BiologicsTerminatedNCT04870411
• The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19)Status unknownNCT04844515
• Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised PeopleCompletedNCT04844489Not applicable
• EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19CompletedNCT04822818Phase 3
• MIcrovascular Dysfunction in CRitically Ill cOVID-19 PatientsStatus unknownNCT04819802
• Risk of Contamination by COVID-19 During Oral Care With AerosolizationCompletedNCT04817319Not applicable
• ANTIcoagulation in Severe COVID-19 PatientsCompletedNCT04808882Phase 2
• Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)Status unknownNCT04748471Phase 2
• COVID-19. CT-Scan Modeling in COVID19 SequelaeStatus unknownNCT04747769
• Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory FailureCompletedNCT04733105
• Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-surveyStatus unknownNCT04732858
• Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19CompletedNCT04724395
• Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical CareCompletedNCT04704388
• Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)CompletedNCT04703114Not applicable
• Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19Status unknownNCT04677478
• Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized PatientsStatus unknownNCT04669938
• Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 PatientsTerminatedNCT04654325Not applicable
• Impact of Adipose Tissue in COVID-19Status unknownNCT04639440
• Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of CasesStatus unknownNCT04639427
• Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) EpidemicCompletedNCT04625296
• Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 InfectionStatus unknownNCT04624997
• FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 PneumoniaCompletedNCT04618042Phase 2
• Laparoscopy and COVID-19 ContaminationStatus unknownNCT04608383
• CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult PatientsTerminatedNCT04608266Phase 3
• Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized PatientsCompletedNCT04608201Phase 3
• Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit PatientsCompletedNCT04598594Phase 3
• Myeloid Cells in Patients With Covid-19 PneumoniaWithdrawnNCT04590261Not applicable
• Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19CompletedNCT04590222
• Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent AcrosyndromeWithdrawnNCT04590209Not applicable
• French Cohort of COVID-19 Patients With Post-intensive Care SyndromeCompletedNCT04590170
• SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory RheumatismTerminatedNCT04584541Not applicable
• Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19)CompletedNCT04583761
• Efficacy of Nicotine in Preventing COVID-19 InfectionStatus unknownNCT04583410Phase 3
• Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on SalivaCompletedNCT04578509
• Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)CompletedNCT04568707Not applicable
• COVID-Impact "Psychological IMPACT of Covid-19 on AP-HP Staff"Status unknownNCT04558437
• Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational StudyCompletedNCT04527198Not applicable
• Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum DepressionStatus unknownNCT04516668
• Assessment of SARS-CoV-2 Seroprevalence in DetentionCompletedNCT04516512Not applicable
• Coronavirus Studied by Metagenomics in ARDS COVID-19 PatientsStatus unknownNCT04516486
• Covid-19 in Pregnancy: a French Population-based Cohort of Women and NewbornsCompletedNCT04463758
• Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HPCompletedNCT04442087Not applicable
• Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in ChildrenCompletedNCT04420468
• Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP)CompletedNCT04418375
• COVID-19 Infection and Transmission in Exposed, Confined and Community-based InfantsCompletedNCT04413968Not applicable
• Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19Status unknownNCT04413864Not applicable
• Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19Status unknownNCT04405492Not applicable
• COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ CellsStatus unknownNCT04402892Not applicable
• COVID-19 Infection in Healthcare WorkersCompletedNCT04386759
• Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care WorkersStatus unknownNCT04384549Phase 3
• Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19CompletedNCT04379466
• Developement and Evaluation of Serological Assays for COVID-19Status unknownNCT04377763
• COVID19-FOIE National ObservatoryCompletedNCT04375670
• Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 PatientsWithdrawnNCT04371406Phase 3
• Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological ImpactCompletedNCT04366817Not applicable
• Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 InfectionsCompletedNCT04365725
• Observational Cohort of COVID-19 Patients at Raymond-PoincareStatus unknownNCT04364698
• COVID-19 Infection: Exploration of Respiratory Control Center AbnormalitiesCompletedNCT04363749Not applicable
• Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences)CompletedNCT04362930
• Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related PneumoniaCompletedNCT04357457Phase 3
• Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19CompletedNCT04357444Phase 2
• Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it WorseStatus unknownNCT04356417
• Epidemiological Characteristics of COVID-19 in Patients With MS or NMOCompletedNCT04355611
• Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19CompletedNCT04355533Not applicable
• Computed Tomography for COVID-19 DiagnosisCompletedNCT04355507
• Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care UnitStatus unknownNCT04355481
• Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)Status unknownNCT04355429Phase 2
• Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of BeingCompletedNCT04352348Not applicable
• CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 CohortStatus unknownNCT04346797Phase 2